---
title: "ACC.25: Rivaroxaban “a viable alternative to warfarin” in STEMI patients with left-ventricular thrombus"
date: "2025-03-29T20:41:21.000Z"
publishedDate: "29 mars 2025"
summary: "At three months of follow-up, patients hospitalised for a serious heart attack who were treated with the oral blood thinner rivaroxaban for a blood clot in the left ventricle did as well as similar patients who received standard treatment with warfarin, an older blood-thinning drug. This is according to findings of the RIVAWAR trial, presented [&#8230;] The post ACC.25: Rivaroxaban “a viable alternative to warfarin” in STEMI patients with left-ventricular thrombus appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/acc-25-rivaroxaban-a-viable-alternative-to-warfarin-in-stemi-patients-with-left-ventricular-thrombus/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-03-29-acc25-rivaroxaban-a-viable-alternative-to-warfarin-in-stemi-patients-with-left-ventricular-thrombus"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/03/ACC_PM_0256-scaled.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/acc-25-rivaroxaban-a-viable-alternative-to-warfarin-in-stemi-patients-with-left-ventricular-thrombus/"
---

![ACC.25: Rivaroxaban “a viable alternative to warfarin” in STEMI patients with left-ventricular thrombus](https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/03/ACC_PM_0256-scaled.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/acc-25-rivaroxaban-a-viable-alternative-to-warfarin-in-stemi-patients-with-left-ventricular-thrombus/*

## L’essentiel

At three months of follow-up, patients hospitalised for a serious heart attack who were treated with the oral blood thinner rivaroxaban for a blood clot in the left ventricle did as well as similar patients who received standard treatment with warfarin, an older blood-thinning drug. This is according to findings of the RIVAWAR trial, presented [&#8230;] The post ACC.25: Rivaroxaban “a viable alternative to warfarin” in STEMI patients with left-ventricular thrombus appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/acc-25-rivaroxaban-a-viable-alternative-to-warfarin-in-stemi-patients-with-left-ventricular-thrombus/
